Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Maze Therapeutics, Inc. | 15,000 | reported | 14 May 2026 | tx 34+262,000−300,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | EXERCISE | Maze Therapeutics, Inc. | 15,000 | 10.42 USD | 10b5-1 |
| 14 May 2026 | SALE | Maze Therapeutics, Inc. | 15,000 | 26.22 USD | 10b5-1 |
| 14 May 2026 | EXERCISE | Maze Therapeutics, Inc. | 15,000 | 0.00 USD | 10b5-1deriv |
| 20 Mar 2026 | SALE | Maze Therapeutics, Inc. | 6,161 | 48.20 USD | |
| 20 Mar 2026 | SALE | Maze Therapeutics, Inc. | 3,795 | 49.32 USD | |
| 20 Mar 2026 | EXERCISE | Maze Therapeutics, Inc. | 15,000 | 10.42 USD | |
| 20 Mar 2026 | SALE | Maze Therapeutics, Inc. | 5,044 | 50.02 USD | |
| 20 Mar 2026 | EXERCISE | Maze Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 10 Mar 2026 | EXERCISE | Maze Therapeutics, Inc. | 30,000 | 10.42 USD | |
| 10 Mar 2026 | SALE | Maze Therapeutics, Inc. | 348 | 51.02 USD | |
| 10 Mar 2026 | SALE | Maze Therapeutics, Inc. | 29,652 | 50.45 USD | |
| 10 Mar 2026 | EXERCISE | Maze Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Maze Therapeutics, Inc. | 48,000 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Maze Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 02 Feb 2026 | EXERCISE | Maze Therapeutics, Inc. | 15,000 | 10.42 USD | |
| 02 Feb 2026 | SALE | Maze Therapeutics, Inc. | 600 | 44.21 USD | |
| 02 Feb 2026 | SALE | Maze Therapeutics, Inc. | 8,364 | 45.89 USD | |
| 02 Feb 2026 | SALE | Maze Therapeutics, Inc. | 100 | 47.23 USD | |
| 02 Feb 2026 | SALE | Maze Therapeutics, Inc. | 5,936 | 46.37 USD | |
| 02 Feb 2026 | EXERCISE | Maze Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 25,156 | 10.42 USD | |
| 07 Jan 2026 | SALE | Maze Therapeutics, Inc. | 25,156 | 40.20 USD | |
| 07 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 25,156 | 0.00 USD | deriv |
| 05 Jan 2026 | EXERCISE | Maze Therapeutics, Inc. | 412 | 10.42 USD | |
| 05 Jan 2026 | SALE | Maze Therapeutics, Inc. | 412 | 40.00 USD |